QLENX
Price
$21.43
Change
+$0.12 (+0.56%)
Updated
Aug 21 closing price
Net Assets
8.61B
SRUIX
Price
$17.38
Change
+$0.09 (+0.52%)
Updated
Aug 21 closing price
Net Assets
276.1M
Interact to see
Advertisement

QLENX vs SRUIX

QLENX vs SRUIX Comparison Chart in %
View a ticker or compare two or three
VS
QLENX vs. SRUIX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QLENX is a Hold and SRUIX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
QLENX has more cash in the bank: 8.61B vs. SRUIX (276M). QLENX pays higher dividends than SRUIX: QLENX (1.62) vs SRUIX (0.82). QLENX was incepted earlier than SRUIX: QLENX (13 years) vs SRUIX (10 years). QLENX (6.06) is less costly to investors than SRUIX (1.58). QLENX is a more actively managed with annual turnover of: 296.00 vs. SRUIX (240.00). QLENX has a lower initial minimum investment than SRUIX: QLENX (2500) vs SRUIX (1000000). SRUIX annual gain was more profitable for investors over the last year : 18.63 vs. QLENX (16.94). QLENX return over 5 years is better than : 178.83 vs. SRUIX (28.59).
QLENXSRUIXQLENX / SRUIX
Total Expense Ratio6.061.58384%
Annual Report Gross Expense Ratio6.061.58384%
Fund Existence13 years10 years-
Gain YTD4.23213.71431%
Front LoadN/AN/A-
Min. Initial Investment250010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets8.61B276M3,118%
Annual Yield % from dividends1.620.82198%
Returns for 1 year16.9418.6391%
Returns for 3 years94.3339.66238%
Returns for 5 years178.8328.59625%
Returns for 10 years156.72N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MELAX17.730.16
+0.91%
Morgan Stanley Inst EMkts Ldrs A
SNXFX16.490.08
+0.49%
Schwab 1000 Index®
JHTAX21.920.08
+0.37%
JPMorgan Hedged Equity 3 A
KLCAX16.410.05
+0.31%
Federated Hermes Kaufmann Large Cap A
FACSX56.420.10
+0.18%
Nuveen Mid Cap Value Opportunities C